Intraop Medical becomes a publicly traded company

[March 2005]  Intraop Medical, Inc. became a publicly traded company on March 9, 2005 by merging with an existing public company, Intraop Medical Corporation. The Company’s new name will be Intraop Medical Corporation (IOPM.ob)

    The Company will continue its business of developing, manufacturing, marketing and servicing the Mobetron, a mobile electron beam system designed for intraoperative radiation therapy treatment of cancer, coronary/vascular restenosis and other medical applications. To date, the Company has twelve Mobetron installations in the United States, Europe, and Asia.

    The Company's operations will continue to be conducted from its facilities in Santa Clara, California. The Company retains its current management and Board of Directors.

    For more information on this event, please refer to the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), including the Company's most recent forms 10QSB and 10KSB and the Company's definitive information statement, for a description of certain important factors, risks and uncertainties that may affect the Company's business.

You may read and copy any reports and other information filed by the Company at the SEC's public reference room(s) at 450 Fifth Street, N.W., Washington, D.C. 20549. These documents are also available free of charge at the SEC's web site at www.sec.gov.